Cue Health Inc.: restructuring charge — Cue Health reduces workforce by 26% (388 employees) in cost reduction plan

Cue Health Inc.

Workforce reduction of 388 employees (~26% of global staff) announced Jan 5, 2023.
Estimated cash restructuring charges of $6.0M to $8.0M; non-cash equity charges ~$0.2M.
CEO Ayub Khattak cites pandemic demand decline and uncertain regulatory timelines for new products.
Pipeline progress noted: Flu+COVID test, RSV, strep, chlamydia/gonorrhea, Mpox submissions underway.
Severance includes min 9 weeks pay, PTO payout, healthcare through March 2023, partial equity acceleration.

Key facts

Extracted from this filing and checked against the source text.

Restructurings & Charges SEC 8-K Item 2.05/2.06 confidence 0.9

Cue Health Inc. announced a restructuring with charges of approximately $6.0 million to $8.0 million (388 employees, which constitutes a reduction of approximately 26% in the Company’s global workforce).

Type: restructuring
Charge: approximately $6.0 million to $8.0 million
Headcount: 388 employees, which constitutes a reduction of approximately 26% in the Company’s global workforce

Exact text from the filing

The CRP will include a reduction in the Company’s employee base by 388 employees, which constitutes a reduction of approximately 26% in the Company’s global workforce. In connection with the CRP, the Company estimates that it will record an aggregate restructuring charge related to one-time termination benefits in the range of approximately $6.0 million to $8.0 million.

View on SEC.gov

Browse all restructurings & charges →

Source: SEC EDGAR

accession 0001628945-23-000002

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.